Skip to main content
University of California San Francisco
UCSF School of Medicine | Department of Pediatrics UCSF Medical Center

Concordant lipoprotein and weight responses to dietary fat change in identical twins with divergent exercise levels 1.

  • Read more about Concordant lipoprotein and weight responses to dietary fat change in identical twins with divergent exercise levels 1.

The protease inhibitor PI*S allele and COPD: a meta-analysis.

  • Read more about The protease inhibitor PI*S allele and COPD: a meta-analysis.

Elevated allergen-induced IL-13 secretion predicts IgE elevation in children ages 2-5 years.

  • Read more about Elevated allergen-induced IL-13 secretion predicts IgE elevation in children ages 2-5 years.

Hypoxia-inducible factor-dependent histone deacetylase activity determines stem cell fate in the placenta.

  • Read more about Hypoxia-inducible factor-dependent histone deacetylase activity determines stem cell fate in the placenta.

Pathophysiology and treatment of sickle cell disease.

  • Read more about Pathophysiology and treatment of sickle cell disease.

Connexin 40, a target of transcription factor Tbx5, patterns wrist, digits, and sternum.

  • Read more about Connexin 40, a target of transcription factor Tbx5, patterns wrist, digits, and sternum.

Hippocampal and visuospatial learning defects in mice with a deletion of frizzled 9, a gene in the Williams syndrome deletion interval.

  • Read more about Hippocampal and visuospatial learning defects in mice with a deletion of frizzled 9, a gene in the Williams syndrome deletion interval.

Trends in complete blood count values during acute painful episodes in children with sickle cell disease.

  • Read more about Trends in complete blood count values during acute painful episodes in children with sickle cell disease.

Barriers to adherence of deferoxamine usage in sickle cell disease.

  • Read more about Barriers to adherence of deferoxamine usage in sickle cell disease.

Use of recombinant factor VIIa for refractory hemorrhage during extracorporeal membrane oxygenation.

  • Read more about Use of recombinant factor VIIa for refractory hemorrhage during extracorporeal membrane oxygenation.

Pagination

  • Previous page ‹‹
  • Page 189
  • Next page ››
Subscribe to

Pediatrics Home

MAKE A GIFT

© 2026 The Regents of the University of California. The University of California San Francisco  |  UCSF Department of Pediatrics                                                                                   Accessibility  Privacy Policy  Terms of Use  A-Z Website List